Compare Abeona Therapeutics Inc (ABEO) vs United States Copper Index Fund (CPER) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs United States Copper Index Fund — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while United States Copper Index Fund trades at $37.03. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, United States Copper Index Fund nearer its low. Which is the better fit depends on your goals.
| ABEO | CPER | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $7.23 | $40.60 |
52-Week Low | $4.17 | $27.21 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
CPER, the United States Copper Index Fund ETF, trades at $37.84, up 1.47% today. The technical outlook is mixed, with a bullish moving average signal but neutral overall momentum. Recent news highlights strong copper demand from AI and electric vehicles, though supply constraints and price volatility are key themes. Financial ratios are not applicable as this is a commodity ETF tracking copper futures.
The outlook for CPER is tied to copper's structural bull market, driven by AI and green energy demand. Risks include global manufacturing weakness and commodity price swings. Investor sentiment is positive due to copper's supply-demand imbalance, but the ETF's performance remains sensitive to macroeconomic factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About United States Copper Index Fund
CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.
Read more on CPER →
